Rapamicina: una opción de tratamiento en el linfangioma circunscrito adquirido de la vulva

• Daniela Ramírez-Martínez ^[1] ; Silvana Castillo-Loaiza ^[1] ; Liliana Muñoz-García ^[1]
  1. [1] Universidad Icesi

     Universidad Icesi

     Colombia

     
• Localización: Piel: Formación continua en dermatología, ISSN 0213-9251, Vol. 39, Nº. 6 (Junio-Julio), 2024, págs. 368-370
• Idioma: español
• DOI: 10.1016/j.piel.2023.10.003
• Títulos paralelos:
  • Rapamycin: A treatment option for acquired circumscribed lymphangioma of the vulva
• Enlaces
  • Texto Completo Ejemplar
• Referencias bibliográficas
  • Yoon G, Kim HS, Lee YY, et al. Clinical outcomes of primary surgical treatment for acquired vulvar lymphangioma circumscriptum. Arch Gynecol...
  • Valente K, Montgomery K, Schultenover S, et al. Acquired vulvar lymphangioma circumscriptum after cervical cancer treatment: case report....
  • Liu X, Cheng C, Chen K, et al. Recent progress in lymphangioma. Front Pediatr. 2021(9):735832. https://doi.org/10. 3389/fped.2021.735832.
  • Gomides MDA, Costa LD, Berbert ALCV, et al. Cutaneous lymphangioma circumscriptum: the relevance of clinical, dermoscopic, radiological, and...
  • Dill Patricia E, De Bernardis Gaston, Weber Peter, Lösch Uli. Topical everolimus for facial angiofibromas in the tuberous sclerosis complex....
  • Topical rapamycin in facial angiofibromas: assessment of clinical improvement and patient satisfaction in a series of 4 cases. J Am Acad Dermatol....